Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer

Ductal adenocarcinoma of the prostate: Clinical and biological profiles

(2017) Armelle Vinceneux et al.   PROSTATE

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

(2017) Dung T. Le et al.   SCIENCE

Treatment strategies for DNA repair-deficient prostate cancer

(2017) Benjamin A. Teply et al.   Expert Review of Clinical Pharmacology

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

(2016) Mary B. Daly et al.   Journal of the National Comprehensive Cancer Network

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

(2016) Colin C. Pritchard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stage at presentation and survival outcomes of patients with Gleason 8–10 prostate cancer and low prostate-specific antigen

(2016) Aaron D. Falchook et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Integrative Clinical Genomics of Advanced Prostate Cancer

(2015) Dan Robinson et al.   CELL

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

(2015) Gail P. Risbridger et al.   EUROPEAN UROLOGY

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

(2015) Joaquin Mateo et al.   NEW ENGLAND JOURNAL OF MEDICINE

ClinVar: public archive of interpretations of clinically relevant variants

(2015) Melissa J. Landrum et al.   NUCLEIC ACIDS RESEARCH

Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens

(2014) Kyosuke Kimura et al.   PROSTATE

GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

(2013) Elena Castro et al.   JOURNAL OF CLINICAL ONCOLOGY

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

(2012) Jonathan Ledermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer

(2010) D. J. Gallagher et al.   CLINICAL CANCER RESEARCH

Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease

(2009) Anthony V. D'Amico et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostatic Ductal Adenocarcinoma: A Mini Review

(2009) Jonathan I. Epstein   MEDICAL PRINCIPLES AND PRACTICE

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE